Summary:
- This article discusses how some biotech companies are using digital coins and cryptocurrencies to try to boost their stock prices.
- Biotech companies are exploring ways to incorporate blockchain technology and digital tokens into their business models, hoping to attract investor interest and increase their market value.
- The article suggests that this trend is driven by the desire of biotech firms to find new ways to raise capital and generate excitement around their companies, even if the connection to their core business activities is not always clear.